Join/Renew Now

Zero Tolerance Anti-Doping Newsletter
Volume 3, Issue 3 - April 2006

In This Issue

Why Zero Tolerance?

USA Track & Field CEO Craig A. Masback and USATF President Bill Roe developed the plan in concert with the USATF Board of Directors in October 2003 by combining existing programs and USATF priorities with ambitious new initiatives. "Zero Tolerance" focuses on three goals: increasing efforts to catch and punish cheaters; expanding educational efforts and focusing the message on the theme that cheating is wrong and cheaters will be caught; and taking a more visible role on these issues.


WADA Introduces Doping Quiz - Test your Knowledge

WADA has announced the launch of their new Doping Quiz, an online interactive tool to educate athletes about the dangers and consequences of doping.

The Doping Quiz, an integral part of WADA's Athlete Outreach Program (as seen at the 2005 Helsinki World Championships), can be played in nine different languages, including English, French, Spanish, Italian, German, Greek, Chinese, Portuguese, and Russian.

Test your knowledge about the fight against doping in sport and play the Doping Quiz.


Latest News

USADA 2005 Testing Numbers Announced

USADA announced their final testing number for 2005. The agency performed a total of 8,175 doping control tests in 67 Olympic, Paralympic and Pan American sports, including 7,675 domestic tests. Out-of-competition (OOC) testing comprised approximately 61% (4,976) of the domestic tests USADA conducted in 2005. In the fourth quarter alone, USADA performed 1,583 domestic tests, including 953 OOC tests. For track and field, 1,423 total tests were conducted in 2005. USATF tests accounted for 19 percent of USADA's domestic testing, and is 52 percent more than the second most tested Olympic sport - swimming (743 overall tests) in 2005. USADA announced 22 anti-doping rules violations in 2005, including four non-analytical positives and three test refusals.

Changes announced in Albuterol Inhalers

Due to recent FDA actions, manufacturers of albuterol sulfate metered-dose inhalers were required to change the propellant in previous formulations which has led to the following situation:

  1. All previously manufactured product stores will be depleted and will no longer be available.
  2. The only remaining albuterol formulations will be Ventolin-HFA and Proventil-HFA, which utilize a different propellant, until their patent expires.
  3. Market availability of Ventolin-HFA and Proventil-HFA has been sporadic at best.
  4. The remaining beta-agonist 'rescue' inhalers include Alupent (metaproteronol) and Maxair (pirbuterol).
  5. Long-acting beta-agonists include Serevent (salmeterol) and Foradil (formoterol). These drugs are not suitable for PRN use as their onset of action is less than 30 minutes.
  6. Alupent has a cost of less than half that of Maxair.
  7. There is no date when the HFA formulations will be available again.

This information is courtesy of www.sportpharm.com. Athletes who use inhalers should consult with their prescribing physician to see if they need to alter their medications.

Athletes Advantage

Get your advantage with USADA's Athlete's Advantage program, which provides tools and resources to athletes more easily comply with anti-doping rules and policies.

The Athlete's Advantage Toolkit is a handy three-ring calendar binder containing important USADA publications, and is available to athletes in the Out-of-Competition (OOC) testing program. USADA launched the Athlete's Advantage Online to help athletes in the OOC testing program to learn how and where to access anti-doping resources. Athletes in the OOC testing program can sign up to receive the Toolkit while going through the online project, by e-mailing educationnews@usantidoping.org or calling 866-601-2632 x2044 or 719-785-2044. USADA publications are available to all athletes.

Reminder to Athletes in the USADA Out of Competition Testing Pool

Athlete Location Forms are due to USADA on June 1 for the 3rd quarter of 2006. If you have a question about your status in the USADA OOC Pool, please contact USATF's Melissa Beasley at 317-713-4650.

Athletes can submit forms electronically or via fax (719-785-2099). Forms can also be mailed to USADA at 1330 Quail Lake Loop, Suite 260, Colorado Springs, CO 80906.

USATF recommends that athletes always keep a copy of their quarterly athlete location form after they have submitted it to USADA for their personal records.


IAAF Announces New ATUE Protocol for 2006

In response to an increase in the use of Beta-2 Agonists by athletes, the IAAF Council has endorsed a recommendation from the IAAF Medical and Anti-Doping Commission to require more detailed information from applicants who seek an exemption for the use of Beta-2 Agonists for asthma and/or exercise-induced asthma or exercise-induced bronchoconstriction, and/or other clinical respiratory diseases requiring specific treatment.

Applicants seeking the use of the four Beta-2 Agonists (formeterol, salbutamol, salmeterol and terbutaline) will be required to submit the following information:

  1. An IAAF Abbreviated TUE Application Form including detailed medical records. The application can be downloaded at www.iaaf.org/antidoping.
  2. Objective evidence of asthma and/or exercise-induced asthma or exercise-induced bronchoconstriction, and/or other clinical respiratory diseases requiring specific treatment through the provision of test results and supporting documentation as set forth in the provocation test results requirements. **ALL TESTS MUST BE PERFORMED AFTER JANUARY 1, 2005.

**Note - if you currently have a valid ATUE on file - you do not need to resubmit your application and new test results until your ATUE expires and you need to renew

The IAAF has also developed a Detailed Medical Records form that athletes can take to their physician to have them complete the form and control the amount of detailed medical records that are submitted to the IAAF. This application can be download at www.iaaf.org/antidoping.

For athletes who have well-controlled asthma with negative response to all the tests - the IAAF has acknowledged the exceptional cases of athletes with known, but well-controlled, asthma reporting 'negative' results from the bronchial provocation tests, while applying for the use of inhaled Beta-2 Agonists, the following documentation must be enclosed, in addition to negative results obtained in the bronchial provocation tests: a complete report from personal physician on medical history, including reports on hospital emergency department attendance or admission for acute exacerbations of asthma and on previous treatment with different medications, including systemic corticosteroids, and any additional information that might be helpful for the diagnosis.

Athletes who have questions regarding these changes to the IAAF Protocol are encouraged to contact USADA's Camila Zardo at 719-785-2045 as they begin the application process or the application renewal process.


2006 USADA Wallet Cards Are Now Available

USADA recently posted the 2006 USADA/WADA Prohibited Substances and Prohibited Methods Wallet Card online for athletes, coaches and trainers to download and print for reference. The Wallet Cards will also be available at various Visa Championship Series Events throughout the indoor and outdoor season.

Visit the USADA website for the updated Wallet Cards (PDF).

Please note that the list online is not complete and is subject to change. USATF recommends that athletes call the USADA Drug Reference line with questions about medications not listed on the Wallet Card at 1-800-233-0393.


Upcoming Events

April 29 USA vs. The World at the Penn Relays, Philadelphia, PA
May 21 adidas Track Classic, Carson, CA
May 28 Nike Prefontaine Classic, Eugene, OR
June 3 Reebok Grand Prix, New York, NY
June 21-25 AT&T USA Outdoor Track & Field Championships, Indianapolis, IN
July 7-9 NACAC Under-23 Championships, Santo Domingo, DR
Aug. 5-6 USA/GBR Combined Events Dual Meet, Manhattan, KS
Aug. 8 PAA Mid-Summer's Twilight Classic, Eugene, OR
Aug. 19-20 USA/GBR/RUS/CHN Meet, Birmingham, GBR
Sept. 9-10 IAAF World Athletics Final, Stuttgart, GER
Sept. 16-17 IAAF World Cup, Athens, GRE

Did You Know?

USA Track & Field has recently updated our in-house phone system, and all staff members now have a direct-dial number. Please visit our online organizational directory to see the numbers of USATF staff members you call regularly so you can update your records to reflect the new direct-dial numbers.


Important Numbers

  • USADA Drug Reference Line - 800-233-0393 (toll free)
  • USATF Whistleblower Hotline - 866-809-8104 (toll free)
  • USATF Anti-Doping Liaison (Melissa Beasley) - 317-713-4650

Links to other Anti-Doping Websites

Nike Visa BMW Gatorade Gill Athletics St. Vincent Lynx